Immunodeficiency Syndrome: Clinical Trials

1 trial for Immunodeficiency Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Immunodeficiency Syndrome: new trials by email Literature Review of Immunodeficiency Syndrome trials Research Report on Immunodeficiency Syndrome

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
Alemtuzumab, Allogeneic Bone Marrow Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation - Immunodeficiency Syndrome, Non-Cancer Diagnosis
Phase 2CompletedFred Hutchinson Cancer Center292006-06-012020-02-17

Narrower conditions

Immunologic Deficiency Syndromes (1)

Broader conditions

Immune System Diseases (1)

Interventions

Alemtuzumab (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Mycophenolic Acid (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)

Sponsors

Fred Hutchinson Cancer Center (1)

Countries

United States (1)

Top investigators

Lauri Burroughs (1)

NIH funding

P30CA015704 (1)